Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Rodríguez, J., Shearer, B., & Slawson, D. C. (2007). Metformin Therapy and Diabetes Prevention in Adolescents Who Are Obese. American Family Physician. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_fmr-0003
No studies have addressed the question of whether metformin reduces development of diabetes among adolescents who are obese. Metformin treatment in adolescents who are obese can modestly reduce risk factors for type 2 diabetes, including elevated body mass index (BMI), fasting insulin levels, and fasting glucose levels. (Strength of Recommendation [SOR]: C). However, metformin treatment is associated with nausea, abdominal pain, and diarrhea. (SOR: A). Because of the limited available data, metformin is not recommended for diabetes prevention in adolescents. (SOR: C).
Rodríguez, J., Shearer, B., & Slawson, D. C. (2007). Metformin Therapy and Diabetes Prevention in Adolescents Who Are Obese. American Family Physician. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_fmr-0003
